These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 2542061
1. Analogues of vasoactive intestinal peptide (VIP) contract the guinea-pig uterine artery but do not antagonize VIP-induced relaxations. Morris JL, Murphy R. Eur J Pharmacol; 1989 Mar 21; 162(2):375-9. PubMed ID: 2542061 [Abstract] [Full Text] [Related]
2. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages. Pozo D, Montilla ML, Guerrero JM, Calvo JR. Eur J Pharmacol; 1997 Mar 05; 321(3):379-86. PubMed ID: 9085051 [Abstract] [Full Text] [Related]
3. The effects of vasoactive intestinal peptide (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle. Ellis JL, Farmer SG. Br J Pharmacol; 1989 Mar 05; 96(3):513-20. PubMed ID: 2720290 [Abstract] [Full Text] [Related]
4. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum. Grider JR, Rivier JR. J Pharmacol Exp Ther; 1990 May 05; 253(2):738-42. PubMed ID: 2110976 [Abstract] [Full Text] [Related]
5. The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro. Bhogal R, Sheldrick RL, Coleman RA, Smith DM, Bloom SR. Peptides; 1994 May 05; 15(7):1237-41. PubMed ID: 7854975 [Abstract] [Full Text] [Related]
11. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle. Chakder S, Rattan S. J Pharmacol Exp Ther; 1993 Jul 05; 266(1):392-9. PubMed ID: 8392560 [Abstract] [Full Text] [Related]
12. Neuropeptide Y inhibits relaxations of the guinea pig uterine artery produced by VIP. Morris JL. Peptides; 1990 Jul 05; 11(2):381-6. PubMed ID: 1972575 [Abstract] [Full Text] [Related]
15. Pregnancy does not alter the response of uterine arteries to vasoactive intestinal polypeptide. Jovanovic S, Grbovic L, Jovanovic A. Mol Hum Reprod; 2000 Apr 13; 6(4):361-8. PubMed ID: 10729319 [Abstract] [Full Text] [Related]
16. Involvement of K+ channels in the relaxant effect of vasoactive intestinal peptide and atrial natriuretic peptide in isolated guinea-pig trachea. Thirstrup S, Nielsen-Kudsk JE, Mellemkjaer S. Eur J Pharmacol; 1997 Jan 29; 319(2-3):253-9. PubMed ID: 9042598 [Abstract] [Full Text] [Related]
18. Structure-activity studies of vasoactive intestinal peptide (VIP): cyclic disulfide analogs. Bolin DR, Cottrell J, Garippa R, O'Neill N, Simko B, O'Donnell M. Int J Pept Protein Res; 1993 Feb 29; 41(2):124-32. PubMed ID: 8384606 [Abstract] [Full Text] [Related]
19. The effects of antagonists of vasoactive intestinal peptide on nonadrenergic noncholinergic inhibitory responses in feline airways. Thompson DC, Altiere RJ, Diamond L. Peptides; 1988 Feb 29; 9(2):443-7. PubMed ID: 3131749 [Abstract] [Full Text] [Related]
20. Effects of vasoactive intestinal polypeptide antagonists on cholinergic neurotransmission in dog and cat trachea. Xie ZQ, Hirose T, Hakoda H, Ito Y. Br J Pharmacol; 1991 Dec 29; 104(4):938-44. PubMed ID: 1667294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]